You are here:Home-Chemical Inhibitors & Agonists-Nuclear Receptor/Transcription Factor-HIF/HIF Prolyl-hydroxylase-BAY 87-2243
BAY 87-2243

Chemical Structure : BAY 87-2243

CAS No.: 1227158-85-1

BAY 87-2243 (BAY87-2243)

Catalog No.: PC-20172Not For Human Use, Lab Use Only.

BAY 87-2243 (BAY87-2243) is a highly potent, selective inhibitor of hypoxia-induced gene activation (IC50=0.7 nM), directly inhibits mitochondrial complex I.

Packing Price Stock Quantity
5 mg $78 In stock
10 mg $118 In stock
25 mg $218 In stock
50 mg $358 In stock
100 mg $548 In stock
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

BAY 87-2243 (BAY87-2243) is a highly potent, selective inhibitor of HIF-1, inhibits hypoxia-induced gene activation (IC50=0.7 nM), directly inhibits mitochondrial complex I.
BAY 87-2243 inhibits hypoxic induction of the HIF target gene CA9 on protein level in HCT116luc cells with IC50 of 2 nM.
BAY 87-2243 inhibits hypoxia-inducible factor (HIF-1α) and HIF-2α protein accumulation in hypoxic H460 cells H460 under hypoxia, but has no effect on HIF-1α protein levels induced by hypoxia mimetics and has no effect on prolyl hydroxylase 2 (PHD2) activity.
BAY 87-2243 suppresses HIF target gene expression in hypoxic lung cancer cells.
BAY 87-2243 inhibits mitochondrial oxygen consumption with IC50 of 10 nM.
BAY 87-2243 potently inhibits cell proliferation of H460 cells with EC50 of 3 nM.
BAY 87-2243 reduces tumor weight, HIF-1α protein, and HIF-1 target gene expression levels in H460 xenograft mouse model.

Physicochemical Properties

M.Wt 525.54
Formula C26H26F3N7O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

1-Cyclopropyl-4-{4-[(5-methyl-3-{3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-1-yl)methyl]pyri-din-2-yl}piperazine

References

1. Ellinghaus P, et al. Cancer Med. 2013 Oct;2(5):611-24.

2. Chang E,et al. Clin Cancer Res. 2015 Jan 15;21(2):335-46.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: